The Design of a Randomized, Placebo-Controlled Trial of Celecoxib in Preprostatectomy Men with Clinically Localized Adenocarcinoma of the Prostate
Authors:
- Elisabeth I. HeathEHElisabeth I. Heath
- Theodore L. DeWeeseTDTheodore L. DeWeese
- Alan W. PartinAPAlan W. Partin
- Angelo M. De MarzoAMAngelo M. De Marzo
- John D. GroopmanJGJohn D. Groopman
- William G. NelsonWNWilliam G. Nelson
- Steven A. PiantadosiSPSteven A. Piantadosi
- Ron LiebermanRLRon Lieberman
- Michael A. CarducciMCMichael A. Carducci
- 1 December 2002
- journal article
- Published by Elsevier in Clinical Prostate Cancer
- Vol. 1 (3) , 182-187
Abstract
No abstract availableThis publication has 28 references indexed in Scilit:
- Cancer Statistics, 2002CA: A Cancer Journal for Clinicians, 2002
- Cyclooxygenase Inhibitors and the Antiplatelet Effects of AspirinNew England Journal of Medicine, 2001
- Risk of Cardiovascular Events Associated With Selective COX-2 InhibitorsJAMA, 2001
- The molecular pathogenesis of prostate cancer: Implications for prostate cancer preventionUrology, 2001
- Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasiaUrology, 2000
- The Effect of Celecoxib, a Cyclooxygenase-2 Inhibitor, in Familial Adenomatous PolyposisNew England Journal of Medicine, 2000
- Proliferative Inflammatory Atrophy of the ProstateThe American Journal of Pathology, 1999
- Mouse embryonic stem cells carrying one or two defective Msh2 alleles respond abnormally to oxidative stress inflicted by low-level radiationProceedings of the National Academy of Sciences, 1998
- Cytidine methylation of regulatory sequences near the pi-class glutathione S-transferase gene accompanies human prostatic carcinogenesis.Proceedings of the National Academy of Sciences, 1994
- A genetic model for colorectal tumorigenesisCell, 1990